NeuroBionics

Cambridge, MA · Founded 2023 · Privately Held (backing)

Developer of a neural interface technology designed to enhance the integration of bioelectronics with the human body. NeuroBionics is based in Cambridge, MA and was founded in 2023. It was valued at $33.3 million at its seed round in Dec 2025, the last priced event on record. It has raised $9.3 million across 1 recorded round; the latest was a $4.2 million seed round in Nov 2025.

PMV mark · valuation
$33.3M
Oct 2026
Priced at
its seed round
Dec 2025
Total raised
$9.3M
Last round
Seed Round
Nov 2025
What is NeuroBionics worth?
$33.3MPrivateMarketView mark · Oct 2026

Valued at $33.3M at its seed round, Dec 2025. Nothing has traded since.

Free account
More of NeuroBionics with a free account
  • ·The complete investor list: 19 names
  • ·Watch NeuroBionics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

NeuroBionics funding history

1 rounds
DateRoundRaisedPost-money
Nov 2025Seed Round$4.2M▮
Unlock post-money valuations

Membership and data by Private Market View

NeuroBionics valuation

NeuroBionics was valued at $33.3 million at its seed round in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has NeuroBionics raised?

NeuroBionics has raised $9.3 million in total; 1 of its rounds is on record. The largest on record was a $4.2 million seed round in Nov 2025.

NeuroBionics has filed 1 Form D with the SEC, most recently in Dec 2025 ($4.2 million sold to 7 investors).

How NeuroBionics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For NeuroBionics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about NeuroBionics

What is NeuroBionics worth?
NeuroBionics is valued at $33.3M as of Oct 2026. Valued at $33.3M at its seed round, Dec 2025. Nothing has traded since.
How much has NeuroBionics raised?
NeuroBionics has raised $9.3M in total funding across 1 recorded rounds.
When did NeuroBionics last raise?
NeuroBionics last raised in Nov 2025 (Seed Round), raising $4.2M.